Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JERROLD L SELZER

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1437191749
CMS profile
109955
Location
CHATTANOOGA, TN

General Payments · PY2018–2023

$3,427.42

  • Reported across 223 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$277.22

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $277.22 16

By paying entity

PY2023 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $803.91 59
PY2019 $304.43 22
PY2020 $559.50 35
PY2021 $429.67 25
PY2022 $1,052.69 66
PY2023 $277.22 16

Payment records · PY2023 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20182019202020212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AbbVie Inc. $19.42 02/21/2023 Food and Beverage Undisputed 01/23/2026 998904687 CMS
Amgen Inc. $14.65 01/04/2023 Food and Beverage Undisputed 01/23/2026 1019964515 CMS
Amgen Inc. $16.39 02/22/2023 Food and Beverage Undisputed 01/23/2026 1020600377 CMS
AstraZeneca Pharmaceuticals LP $14.92 02/06/2023 Food and Beverage Undisputed 01/23/2026 1014498671 CMS
AstraZeneca Pharmaceuticals LP $13.94 03/23/2023 Food and Beverage Undisputed 01/23/2026 1014423647 CMS
Bayer Healthcare Pharmaceuticals Inc. $21.33 01/30/2023 Food and Beverage Undisputed 01/23/2026 1000336619 CMS
Bayer Healthcare Pharmaceuticals Inc. $20.24 02/27/2023 Food and Beverage Undisputed 01/23/2026 1000325637 CMS
GlaxoSmithKline, LLC. $13.24 01/25/2023 Food and Beverage Undisputed 01/23/2026 1001723831 CMS
IDORSIA PHARMACEUTICALS US INC $16.89 02/17/2023 Food and Beverage Undisputed 01/23/2026 1034424863 CMS
Lilly USA, LLC $15.72 02/15/2023 Food and Beverage Undisputed 01/23/2026 1031530089 CMS
Lilly USA, LLC $16.22 03/16/2023 Food and Beverage Undisputed 01/23/2026 1031628983 CMS
Nevro Corp. $18.95 02/20/2023 Food and Beverage Undisputed 01/23/2026 1051759691 CMS
Novo Nordisk Inc $17.37 02/02/2023 Food and Beverage Undisputed 01/23/2026 1000474483 CMS
Novo Nordisk Inc $14.35 03/06/2023 Food and Beverage Undisputed 01/23/2026 1000474475 CMS
Otsuka America Pharmaceutical, Inc. $19.11 03/20/2023 Food and Beverage Undisputed 01/23/2026 1014799611 CMS
Supernus Pharmaceuticals, Inc. $24.48 04/05/2023 Food and Beverage Undisputed 01/23/2026 1053308053 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.